The consequences of DSM-5 for psychiatric diagnosis and psychopharmacotherapy

International Journal of Psychiatry in Clinical Practice

Volumn 18, Issue 2, 2014, Pages 78-85

  Möller, Hans Jürgen ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Classification; Diagnosis; DSM 5; Psychopharmacotherapy

Indexed keywords

ADAPTATION; DEPENDENT PERSONALITY DISORDER; DSM-5; DSM-IV; HUMAN; INTERRATER RELIABILITY; MOOD DISORDER; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; PSYCHOPHARMACOTHERAPY; REVIEW; SCHIZOPHRENIA; CLASSIFICATION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; MENTAL DISORDERS;

DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; HUMANS; MENTAL DISORDERS;

EID: 84901389679     PISSN: 13651501     EISSN: 14711788     Source Type: Journal    
DOI: 10.3109/13651501.2014.890228     Document Type: Review

References (44)

1. American Psychiatric Association.2013. Diagnostic and statistical manual of mental disorders (5th ed.). Arlington, VA: American Psychiatric Publishing.
2. Andreasen NC. 2007. DSM and the death of phenomenology in america: an example of unintended consequences. Schizophr Bull 33 : 108-112. (Pubitemid 46026263)
3. Andrews G, Brugha T, Th ase ME, Duff y FF, Rucci P, Slade T. 2007. Dimensionality and the category of major depressive episode. Int J Methods Psychiatr Res 16 Suppl 1 : S41-S51. (Pubitemid 46930452)
4. Angst J. 2013. Bipolar disorders in DSM-5: strengths, problems and perspectives. Int J Bipolar Disord 1: 12.
5. Berk M. 2013. The DSM-5: Hyperbole, Hope or Hypothesis? BMC Med 11 : 128.
6. Blazer D. 2013. Neurocognitive disorders in DSM-5. Am J Psychiatry 170 : 585-587.
7. Blennow K, Hampel H, Weiner M, Zetterberg H. 2010. Cerebrospinal fl uid and plasma biomarkers in Alzheimer disease. Nat Rev Neurol 6 : 131-144.
8. Cermolacce M, Sass L, Parnas J. 2010. What is bizarre in bizarre delusions? A critical review. Schizophr Bull 36 : 667-679.
9. Clarke DE, Narrow WE, Regier DA, Kuramoto SJ, Kupfer DJ, Kuhl EA, et al. 2013. DSM-5 fi eld trials in the United States and Canada, Part I: study design, sampling strategy, implementation, and analytic approaches. Am J Psychiatry 170 : 43-58.
10. Cuthbert BN, Insel TR. 2013. Toward the future of psychiatric diagnosis: the seven pillars of RDoC. BMC Med 11 : 126.
11. Dimsdale JE. 2013. Somatic Symptom Disorders: a new approach in DSM-5. Die Psychiatrie 10: 30-32.
12. Ewers M, Sperling RA, Klunk WE, Weiner MW, Hampel H. 2011Neuroimaging markers for the prediction and early diagnosis of Alzheimer's disease dementia. Trends Neurosci 34: 430-442.
13. Fava M, Rush AJ, Alpert JE, Balasubramani GK, Wisniewski SR, Carmin CN, et al. 2008. Diff erence in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR * D report. Am J Psychiatry 165: 342-351. (Pubitemid 351704490)
14. Fawcett J. 2010. An overview of mood disorders in the DSM-5. Curr Psychiatry Rep 12: 531-538.
15. Fawcett J. 2013. Aff ective Disorders in DSM-5. Die Psychiatrie 10 : 18-23.
16. Hampel H, Frank R, Broich K, Teipel SJ, Katz RG, Hardy J, et al. 2010. Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives. Nat Rev Drug Discov 9: 560-574.
17. Hyman SE. 2008. Can neuroscience be integrated into the DSM-V? Nat Rev Neurosci 8: 725-732. (Pubitemid 47283150)
18. Insel T. Director's Blog: Transforming Diagnosis. Available from: http://www.nimh.nih.gov/about/director/2013/transformingdiagnosis.shtml.
19. Insel T, Cuthbert B, Garvey M, Heinssen R, Pine DS, Quinn K, et al. 2010. Research domain criteria (RDoC): toward a new classifi cation framework for research on mental disorders. Am J Psychiatry 167 : 748-751.
20. Jager M, Haack S, Becker T, Frasch K. 2011. Schizoaff ective disorder-an ongoing challenge for psychiatric nosology. Eur Psychiatry 26 : 159-165.
21. Koutsouleris N, Borgwardt S, Meisenzahl EM, Bottlender R, Moller HJ, Riecher-Rossler A. 2012. Disease prediction in the at-risk mental state for psychosis using neuroanatomical biomarkers: results from the FePsy study. Schizophr Bull 38 : 1234-1246.
22. Maier W, Zobel A, Wagner M. 2006. Schizophrenia and bipolar disorder: diff erences and overlaps. Curr Opin Psychiatry 19 : 165-170. (Pubitemid 44406128)
23. Maj M. 2013. Mood Disorders in ICD-11 and DSM-5. Die Psychiatrie 10 : 24-29.
24. Moller HJ. 2005. Problems associated with the classifi cation and diagnosis of psychiatric disorders. World J Biol Psychiatry 6: 45-56.
25. Moller HJ. 2008a. The forthcoming revision of the diagnostic and classifi catory system: perspectives based on the European psychiatric tradition. Eur Arch Psychiatry Clin Neurosci 258 : 7-17.
26. Moller HJ. 2008b. Systematic of psychiatric disorders between categorical and dimensional approaches: Kraepelin's dichotomy and beyond. Eur Arch Psychiatry Clin Neurosci 258 : 48-73.
27. Moller HJ. 2009a. Development of DSM-V and ICD-11: tendencies and potential of new classifi cations in psychiatry at the current state of knowledge. Psychiatry Clin Neurosci 63: 595-612.
28. Moller HJ. 2009b. Standardised rating scales in psychiatry: methodological basis, their possibilities and limitations and descriptions of important rating scales. World J Biol Psychiatry 10 : 6-26.
29. Moller HJ. In Press. Dichotomy versus spectrum concept in approaching psychotic disorders: are we ready to make the fi nal decision? In: Soldatos C, Ruiz P, Dikeos D, Riba M, editors. Proceedings of the WPA Th ematic Conference on Intersectional Collaboration 4th European Congress of INA and the 1st Interdisciplinary Congress of HSAPRS, Athens, Greece, Nov 29 to Dec 2, 2012. Pianoro, Italy: Medimond s.r.l.
30. Narrow WE, Clarke DE, Kuramoto SJ, Kraemer HC, Kupfer DJ, Greiner L, Regier DA. 2013. DSM-5 fi eld trials in the United States and Canada, Part III: development and reliability testing of a cross-cutting symptom assessment for DSM-5. Am J Psychiatry 170 : 71-82.
31. Nordgaard J, Arnfred SM, Handest P, Parnas J. 2008. The diagnostic status of fi rst-rank symptoms. Schizophr Bull 34 : 137-154.
32. Nusslock R, Frank E. 2011. Subthreshold bipolarity: diagnostic issues and challenges. Bipolar Disord 13: 587-603.
33. Papakostas GI, Shelton RC, Kinrys G, Henry ME, Bakow BR, Lipkin SH, et al. 2013. Assessment of a multi-assay, serum-based biological diagnostic test for major depressive disorder: a pilot and replication study. Mol Psychiatry 18: 332-339.
34. Phillips KA, Stein DJ, Rauch SL, Hollander E, Fallon BA, Barsky A, et al. 2010. Should an obsessive-compulsive spectrum grouping of disorders be included in DSM-V? Depress Anxiety 27 : 528-555.
35. Regier DA, Kuhl EA, Kupfer DJ. 2013a. The DSM-5: Classifi cation and criteria changes. World Psychiatry 12: 92-98.
36. Regier DA, Narrow WE, Clarke DE, Kraemer HC, Kuramoto SJ, Kuhl EA, Kupfer DJ. 2013b. DSM-5 fi eld trials in the United States and Canada, Part II: test-retest reliability of selected categorical diagnoses. Am J Psychiatry 170: 59-70.
37. Seemuller F, Riedel M, Obermeier M, Schennach-Wolff R, Spellmann I, Meyer S, et al. 2012. The validity of self-rated psychotic symptoms in depressed inpatients. Eur Psychiatry 27 : 547-552.
38. Severus E, Bauer M. 2013. Diagnosing bipolar disorders in DSM-5. Int J Bipolar Disord 1: 14.
39. Stahl SM. 2013. The last Diagnostic and Statistical Manual (DSM): replacing our symptom-based diagnoses with a brain circuit-based classifi cation of mental illnesses. CNS Spectr 18 : 65-68.
40. Starcevic V, Portman ME. 2013. The status quo as a good outcome: How the DSM-5 diagnostic criteria for generalized anxiety disorder remained unchanged from the DSM-IV criteria. Aust N Z J Psychiatry 47: 995-997.
41. Tandon R. 2012. The nosology of schizophrenia: toward DSM-5 and ICD-11. Psychiatr Clin North Am 35: 557-569.
42. Tandon R, Carpenter WT. 2013. Psychotic disorders in DSM-5. Die Psychiatrie 10: 5-9.
43. Trivedi MH, Rush AJ, Wisniewski SR, Nierenberg AA, Warden D, Ritz L, et al. 2006. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR * D: implications for clinical practice. Am J Psychiatry 163: 28-40. (Pubitemid 43050100)
44. World Health Organization. International Classifi cation of Diseases, 10th Revision (ICD-10) [Internet]. Geneva: World Health Organization. Available from: http://apps.who.int/classifi cations/icd10/browse/2010/en